Howton David T
Chief Operating Officer | EVP, General Counsel | SVP, General Counsel
2 companies
Insider Signal Score
31
WeakTrades Analyzed
5
12M Win Rate
0.0%
Avg 3M Return
-16.2%
Avg 12M Return
-34.8%
Howton David T is a Chief Operating Officer at Solid Biosciences Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $1.5M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | SLDB Solid Biosciences Inc. | Chief Operating Officer | Sale+OE | 7,469 | $5.82 | $43,494.23 | -6.6% | +2.7% | - | |
| Dec 3, 2025 | SLDB Solid Biosciences Inc. | Chief Operating Officer | Sale+OE | 4,932 | $5.11 | $25,202.52 | -13.0% | +15.0% | - | |
| Feb 14, 2025 | SLDB Solid Biosciences Inc. | Chief Operating Officer | Sale+OE | 5,561 | $3.96 | $22,021.56 | -18.3% | -35.7% | +53.6% | |
| Dec 3, 2024 | SLDB Solid Biosciences Inc. | Chief Operating Officer | Sale+OE | 5,072 | $5.60 | $28,396.10 | -24.5% | -1.2% | +0.2% | |
| Dec 4, 2023 | SLDB Solid Biosciences Inc. | Chief Operating Officer | Sale+OE | 5,367 | $2.78 | $14,920.26 | -41.1% | +181.7% | +50.6% | |
| Jun 22, 2020 | SRPT Sarepta Therapeutics, Inc. | EVP, General Counsel | Sale+OE | 105,122 | $170.88 | $17,962,831.28 | -22.0% | - | - | |
| Dec 13, 2019 | SRPT Sarepta Therapeutics, Inc. | EVP, General Counsel | Sale+OE | 78,000 | $125.50 | $9,789,000.00 | -75.6% | - | - | |
| Nov 22, 2019 | SRPT Sarepta Therapeutics, Inc. | EVP, General Counsel | Sale+OE | 25,000 | $105.00 | $2,625,000.00 | -35.4% | - | - | |
| Feb 1, 2019 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 30,000 | $140.00 | $4,200,000.00 | -60.5% | - | - | |
| Jul 16, 2018 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 50,000 | $136.46 | $6,823,000.00 | -32.3% | - | - |
Page 1Next →